The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study
Clinical trial NCT06504420 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06504420
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2026-12-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.